Laser-assisted deep sclerectomy better than conventional type

Erbium YAG-laser-assisted deep sclerectomy (DS) offers greatly simplified dissection and better long-term intraocular pressure (IOP) control compared with conventional DS.

Erbium YAG-laser-assisted deep sclerectomy (DS) offers greatly simplified dissection and better long-term intraocular pressure (IOP) control compared with conventional DS, concludes a study published in the March issue of Eye.

Thomas Klink and co-workers from Julius-Maximilians-University and St Vincentius Hospital, Germany examined the data of 14 consecutive patients (10 male, four female) who underwent surgery between 1999 and 2000. The procedure was begun as a standard DS. The deep corneoscleral lamella was dissected with a pulsed Erbium YAG laser (energy: 40-100 mJ, frequency: 5-10 Hz). Schlemm's canal was unroofed and the lamella thinned until aqueous percolated continuously through the membrane.

Mean preoperative IOP was 37.7±10.5 mmHg. The mean postoperative IOP was 16.1±3.9 mmHg at one month, 15.1±4.3 mmHg at three months, 16.4±4.5 mmHg at 12 months and 17.6±8.7 mmHg at 50.5 months. The complete success rates (IOP ≤21 mmHg + IOP reduction ≥ 20% without glaucoma medication) were 83.3% at three months and 50% at 12 and 50.5 months. Rates for qualified success (IOP ≤21 mmHg + IOP reduction ≥ 20% with glaucoma medication) were 91.7% at three months, 92.9% at 12 months and 78.6% 50.5 months. The number of glaucoma medications was reduced from 3.07±0.92 preoperatively to 1.14±1.1 at 50.5 months. The only intraoperative complication requiring iridectomy was a single case of anterior chamber penetration.

It was the conclusion of the authors that Erbium YAG-laser-assisted DS offers better long-term IOP control than standard DS.

Related Videos
Disrupting the glaucoma treatment paradigm with novel femtosecond laser from ViaLase
2-year data in contralateral eye evaluation gives edge to iStent inject over Hydrus stent
Should endocyclophotocoagulation be considered part of MIGS? Mr Ratnarajan delves in
Investigating the effects of canaloplasty on corneal epithelium
POAG study hope to open a new avenue for therapies that are for helping treat patients that develop primary open angle glaucoma
Gonio-intervention robot-assisted glaucoma surgical procedure offers high precision
Investigating best practices for MicroPulse transscleral therapy for glaucoma
Bimatoprost implant successfully lowers IOP in Phase 3 of the ARTEMIS study
Related Content
© 2023 MJH Life Sciences

All rights reserved.